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in explaining variations in population health within a
given year as well as across years within this time period.
Population health levels are further analyzed to examine
whether changes are related to personal and household
characteristics, economic environment, and availability
of medical care inputs.
CONCLUSIONS: These analyses indicate that changes in
health-related quality of life can occur due to factors
other than health-care interventions, a finding which has
important implications for the selection and use of nor-
mative data for interpretation of findings.
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OBJECTIVE: To determine if lost work time differs by
job demand and control among workers with AR. Work
loss estimates were derived for missed workdays, missed
hours, and reduced productivity on days at work while
not feeling well. METHODS: Three different phone in-
terviews were developed to quantify illness-related work
loss. Two different recall periods, at one week and four
weeks, were used for each interview. A convenience sam-
ple (n  20,088) of adult residents from the Baltimore,
MD and Chicago, IL areas was contacted by phone, of
whom 7,691 met occupation eligibility criteria. The inter-
views included questions on job demand and control, and
health questions to screen for AR symptoms and deter-
mine AR severity.
RESULTS: Mean lost work time per week was calculated
among respondents with jobs categorized as high demand-
high control (HH), high demand-low control (HL), low
demand-high control (LH), and low demand-low control
(LL). Among AR cases (n  1596), job demand-control
was significantly (p  .05) related to the number of missed
workdays per week for health reasons, but not to the mean
total hours of lost productive time per week at work while
not feeling well. AR cases in HL jobs missed significantly
more workdays for health reasons than non-AR controls
(1.3 days versus 0.38 days; p  .0001). This was not ob-
served for AR cases in the other demand-control job cate-
gories, or for mild AR cases in HL jobs. Among moderate-
to-severe AR cases in HL jobs, the mean number of missed
workdays increased to 1.74 days per week.
CONCLUSION: AR symptoms are associated with lost
work time. However, the way in which work time is lost
appears to vary with the level of job demand and control.
Given little latitude to adjust work performance to ac-
commodate AR symptoms, individuals in high demand-
low control jobs may be more likely to miss work.
RP2
THE NET COST OF ASTHMA TO A US PUBLIC 
MEDICAID PROGRAM
Pannicker S1, Nielsen K2, Martin BC1
1University of Georigia, Athens, GA, USA; 2GlaxoSmithKline, 
RTP, NC, USA
OBJECTIVE: To determine the net direct medical cost
and utilization patterns of asthma in a public Medicaid
program.
METHODS: A retrospective matched case-control design
was used. Administrative claims data were obtained for
persons eligible for Medicaid benefits in North Carolina
from May 1996 through April 1998. Asthma cases were
defined as persons who had at least one inpatient claim
for asthma (ICD-9-CM  493.) or had two or more out-
patient asthma claims in the first year. A group of control
subjects matched 1 to 1 on age, gender, and race was ob-
tained. Persons who had a diagnosis for emphysema,
COPD, or cancer or who were not between 1 and 65
years of age were excluded. Net costs were determined
using the second year (May 1997 to April 1998) follow-
ing the recruitment period. Adjusted differences were ob-
tained from a generalized least square model using Huber
White heteroscedasticity consistent variance–covariance
matrix with terms to control for comorbidity burden,
Medicare eligibility, and duration of eligibility.
RESULTS: Thirteen thousand two hundred fifty five
asthma cases were identified with a mean age of 16 years,
50% of who were black, and 56% were female. Asthma
cases had a higher comorbidity burden than controls,
particularly for diabetes, psychoses, hypertension, and
anemia. The average total annual cost was $3226 for
asthma cases compared to $2015 (p  .05) for controls.
This translated to a net un-adjusted annual cost of $1210
or $111 per member per month (PMPM). After multi-
variate adjustment, the net annual cost of asthma was es-
timated at $821 and $77 PMPM. Twice as many cases
had emergency room visits and inpatient hospitalizations
than did controls and prescription expenditures were
over 100% higher than controls.
CONCLUSION: Caring for indigent persons with
asthma costs approximately 50% more than for similar
persons without asthma. Inpatient and prescription ex-
penditures account for approximately 50% of the addi-
tional expense.
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OBJECTIVE: The Asthma Symptom Utility Index (ASUI) is
an 11-item asthma-specific health utility instrument devel-
oped in the US. The purpose of this study was to translate
and linguistically validate the ASUI for international use.
METHODS: Seventeen languages were identified: Bul-
garian; Chinese (traditional and simplified); Dutch; Finn-
ish; French; Hebrew; Hungarian; Indonesian; Italian;
Malay; Norwegian; Portuguese; Romanian; Spanish;
Swedish; Turkish. The following method was used for
each translation: two forward translations by native
speakers; one reconciliation of the two forward transla-
tions; one back-translation by an English-speaker fluent
in the target language; three reviews by independent bi-
lingual experts, and final reconciliation by a native-
speaking language coordinator. Pilot-testing and cogni-
tive debriefing interviews were performed with 10 to 15
native-speaking asthma patients in 19 countries. Item and
total score distributions and internal consistency levels
were examined. US-derived item weights were used to es-
timate utility scores.
RESULTS: A total of 290 patients participated in the
evaluation. Mean age of the sample was 48.1 ( 16.8)
years, and 60% were female. Internal consistency esti-
mates (alpha) ranged from 0.74 to 0.90 (mean  0.86).
Mean utility scores ranged from 0.42 ( 0.20) for pa-
tients in Norway (Norwegian; n  10) to 0.88 ( 0.12)
for patients in Israel (Hebrew; n  15). Consistent with
these scores, the Norwegian sample also experienced
more severe symptoms, with more than half reporting
moderate to severe wheezing (5/10) or dyspnea (8/10)
during the previous two weeks compared with 2/15 and
2/15 in the Israeli group, respectively.
CONCLUSIONS: Results suggest the 17 ASUI transla-
tions are culturally acceptable, linguistically valid, and
conceptually equivalent to the original, paving the way for
international asthma-specific, utility-estimation studies.
